Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> FOOD AND DRUG ADMINISTRATION Latest News

NOV 13, 2013 - Yahoo! News

A Must Read - Share

U.S. health regulators approve J&J, Pharmacyclics lymphoma drug

(Reuters) - U.S. health regulators on Wednesday approved a drug to treat a rare and aggressive form of non-Hodgkin lymphoma developed by Johnson & Johnson and Pharmacyclics Inc, marking the second drug that received the FDA's new breakthrough therapy designation to gain approval. The drug, to be sold under the brand name, Imbruvica, and known chemically as ibrutinib, was approved to treat mantle cell lymphoma in patients who have received prior treatment with at least one other medicine, such as Celgene Corp's Revlimid. Mantle cell lymphoma represents about 6 percent of non-Hodgkin lymphoma ... Read More

Tags: U.S. health regulators approve J&J, Pharmacyclics lymphoma drug,  Food And Drug Administration Latest News